Biotech · Private company
Avadel
Track this companyFree. Adds Avadel to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- FT218Phase 3 · Excessive Daytime SleepinessClinicalTrials.gov · fetched Nov 12, 2026
- FT218Phase 3 · Idiopathic HypersomniaClinicalTrials.gov · fetched Nov 12, 2026
- FT218Phase 3 · NarcolepsyClinicalTrials.gov · fetched Nov 12, 2026
- LUMRYZNarcolepsyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Extended-release Sodium Oxybate in ChildrenPHASE2 · RECRUITING · started Oct 27, 2025ClinicalTrials.gov NCT06809803 · fetched Nov 12, 2026
- Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)PHASE3 · COMPLETED · started Aug 1, 2024ClinicalTrials.gov NCT06525077 · fetched Nov 12, 2026
- Observational Study of LUMRYZ in NarcolepsyCOMPLETED · started Jul 18, 2024ClinicalTrials.gov NCT06792708 · fetched Nov 12, 2026
- An Open Label Study of FT218 in Subjects With NarcolepsyPHASE3 · COMPLETED · started Jun 12, 2020ClinicalTrials.gov NCT04451668 · fetched Nov 12, 2026
- Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in NarcolepsyPHASE3 · COMPLETED · started Nov 17, 2016ClinicalTrials.gov NCT02720744 · fetched Nov 12, 2026